CN Stock MarketDetailed Quotes

Zhejiang Hisoar Pharmaceutical (002099)

Watchlist
  • 6.52
  • -0.17-2.54%
Market Closed Jan 16 15:00 CST
10.55BMarket Cap-31.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Hisoar Pharmaceutical (002099) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
API and pharmaceutical intermediates518.71M56.07%
染料及染颜料中间体306.15M33.09%
合同定制业务86.38M9.34%
Other9.43M1.02%
Preparation4.49M0.49%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
medicine609.58M65.89%
Dye306.15M33.09%
Other9.43M1.02%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Abroad499.81M54.02%
Domestic425.35M45.98%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -